The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial.
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; MSD Oncology
 
Janice M. Mehnert
Honoraria - EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; EMD Serono; Merck; Merck
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly
Research Funding - Blueprint Medicines; Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Hugues Pierre Bourgeois
No Relationships to Disclose
 
Manish R. Patel
Speakers' Bureau - Celgene; Exelixis; Genentech/Roche; Taiho Pharmaceutical
 
Donald Gravenor
No Relationships to Disclose
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca
Speakers' Bureau - Amgen; AstraZeneca
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Baxalta; Takeda
 
Matthew H. Taylor
Honoraria - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Novartis; Trillium Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Novartis; Trillium Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Eisai
Travel, Accommodations, Expenses - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Trillium Therapeutics
 
Lucjan Wyrwicz
No Relationships to Disclose
 
Keun-Wook Lee
Consulting or Advisory Role - Merck KGaA; Sanofi/Aventis
Research Funding - AstraZeneca/MedImmune (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Green Cross (Inst); Macrogenics (Inst); Merck KGaA (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Vijay Kasturi
Employment - EMD Serono
 
Kevin M. Chin
Employment - EMD Serono
Leadership - EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - EMD Serono
 
Anja von Heydebreck
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Celgene (Inst); EMD Serono (Inst); Pfizer (Inst)